Board meeting is scheduled for 26th May 2026.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venus Remedies Ltd has scheduled a Board meeting on 26th May 2026 to consider and approve the Audited Standalone and Consolidated Financial Results for Q4 and the year ended 31st March 2026. The meeting will also consider recommending a final dividend for FY2025-26 and matters relating to the ensuing Annual General Meeting. A trading window closure is in effect from 1st April 2026 until 48 hours after the financial results are declared. This is a standard quarterly/annual results announcement with no specific financial metrics or performance indicators disclosed.
This is a routine procedural announcement. Shareholders should note the trading window closure and await the actual financial results for any material impact assessment. The dividend recommendation, if approved, would be a positive signal for investors.